The report, commissioned by the Medical Research Council, Wellcome Trust and Academy of Medical Sciences, focused on the returns from UK investment into research in cardiovascular disease and mental health.
It found that, for each pound invested in cardiovascular disease research by the taxpayer or charity donor, there was a stream of benefits equivalent to earning 39 pence each year forever. Mental health research generated benefits equivalent to 37 pence per pound invested each year forever. The study also found that public and charitable funding of medical research encouraged greater investment from the pharmaceutical industry.
The year-long study focused on results of the investment in research over the period 1975-1992. It was carried out by a consortium involving the Health Economics Research Group at Brunel University, the Office of Health Economics and RAND Europe. The research involved the development of a methodology to calculate the health and GDP (gross domestic product) gains from investing in medical research.
The research was led by Professor Martin Buxton from the Health Economics Research Group, who said: “Estimating the returns on investment in medical research is notoriously difficult. This is partly due to the time it takes for research to filter into measurable health benefits. We looked at the value of health gains, once the cost of healthcare had been taken into account, and gains to the UK’s national income (GDP) from medical research.”
He went on: “Our aim was to generate realistic estimates of the economic impacts of medical research. The methodology we came up with should help to assess the returns for different disease areas. However, this was never intended as a one-off exercise, and we hope our results will stimulate more work in this important but neglected area of research.”
The study showed that there is a time lag between research expenditure and eventual health benefits of approximately 17 years. It also showed that reducing this time lag would improve economic returns. The study has raised further questions, including whether returns on investment differ outside of the time frame studied, or whether returns remain the same, increase or differ depending on the area of research funded. More research is needed to answer these questions.
Data were gathered from UK research funders, including the MRC, Department of Health and Wellcome Trust, to work out total investment in the two chosen disease areas. Evidence-based clinical guidelines, from NICE (the National Institute for Health and Clinical Excellence), were used to estimate the UK’s research contribution to interventions in these fields. 46 different interventions to treat or prevent cardiovascular disease were analysed, for example aspirin, beta blockers and smoking cessation, while the study for mental health used evidence on six such combinations. Quality Adjusted Life Years (QALY), estimated by NICE to be worth around £25,000 each, were used to measure the quantity and quality of life gained from a health intervention.
Professor Martin Roland, the chair of the UK Evaluation Forum Working Group said: “This work will now help us to ask many more searching questions about the areas in which we invest in medical research. It throws into relief the wider importance of investment in medical research for economic growth as well as for social and health benefit.”
Jon Sussex, Deputy Director at the Office of Health Economics added: “In addition to ways of improving people’s length and quality of life, medical research benefits the UK economy. The UK is richer as a result of medical research, as well as healthier.”
Jonathan Grant from RAND Europe said: “The findings demonstrate how important the time lag between basic research and health gain is. The quicker research is translated from bench to bedside, the greater the rate of return. Our study provides empirical support for the strategy to increase funding for translation research in the UK and around the world.”
Sir Leszek Borysiewicz FRS FMedSci, Chief Executive of the MRC, said: “The report provides a fascinating insight into the substantial benefits of medical research. A key message we can take from the findings - particularly during the current economic downturn - is that supporting a wide portfolio of research is very important for future patient and wider economic benefit. It can be hard to see the full potential of research at the outset, but this study shows that investment at an early stage can pay very healthy dividends further down the line.”
Sir John Bell FRS PMedSci, President of the Academy of Medical Sciences, said: “When stripped down to pounds spent and pounds saved it is important that we are able to demonstrate the substantial benefits of medical research to healthcare and the economy. Knowing that investment not only leads to the enrichment of patients lives but also the state of the economy will help to justify continued support during this time of financial uncertainty.”
Peter Hollins, Chief Executive of the British Heart Foundation, said: “As the biggest funder of heart research in the UK, we have always believed in its value. This study lays out in black and white the striking fact that every pound people generously donate today continues to benefit all of us long into the future.”
Andrew McCulloch, Chief Executive of the Mental Health Foundation, said: “We very much welcome the findings of this study. Research is one of the most important weapons we have to tackle the immense challenges that mental illness presents to our society, not least because mental health problems are strongly implicated in most of the major physical diseases we are fighting too.”
Rachel Cummings | alfa
Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT
Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
07.12.2016 | Health and Medicine
07.12.2016 | Life Sciences
07.12.2016 | Health and Medicine